For the seventh week in a row, indicators show that US influenza activity is dropping, but it's still above baseline levels.

The authors assessed the patient characteristics associated with RSV vaccination among older adults hospitalized during the ...

British pharmaceutical giant GlaxoSmithKline and rival Pfizer have agreed to end a lawsuit that alleged Pfizer's respiratory ...

COVID, flu and RSV levels have already hit their peaks. (Pollen levels and springtime allergies are a whole different story.) ...

The bivalent respiratory syncytial virus prefusion F vaccine is highly effective and well tolerated against RSV-associated ...

Older adults and people with certain medical conditions are more likely to receive the respiratory syncytial virus (RSV) ...

GSK Plc and Pfizer Inc. settled a patent-infringement lawsuit over competing vaccines for RSV, ending the dispute in Delaware ...

Children aged 6 months to 12 years are the main spreaders of respiratory syncytial virus (RSV) infections within their ...

More than 190,000 people still sought medical help for acute respiratory infection (ARI), including 30,000 with ...

Pfizer (PFE) and GSK (GSK) settle RSV vaccine patent lawsuit, dismissing the case with prejudice. REad more here.